<DOC>
	<DOCNO>NCT00402519</DOCNO>
	<brief_summary>To assess role interstitial brachytherapy alone compare whole breast irradiation define low-risk group invasive breast cancer ductal carcinoma situ concern local failure ( ipsilateral local recurrence ) affirm hypothesis local control rate arm equivalent .</brief_summary>
	<brief_title>APBI Versus EBRT Therapy After Breast Conserving Surgery Low-risk Breast Cancer</brief_title>
	<detailed_description>To assess role interstitial brachytherapy alone compare whole breast irradiation define low-risk group invasive breast cancer ductal carcinoma situ concern local failure ( ipsilateral local recurrence ) affirm hypothesis local control rate arm equivalent .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Stage 0 , I II breast cancer . Invasive ductal , papillary , mucinous , tubular , medullary lobular carcinoma . Ductal carcinoma situ ( DCIS ) alone . No lymph invasion ( L0 ) hemangiosis ( V0 ) . Lesions &gt; 3 cm diameter , histopathologically confirm . pN0/pNmi ( minimum 6 node specimen , negative sentinel node acceptable ) ; case DCIS alone axillary staging ( e.g . sentinel lymph node biopsy ) optional . M0 . Clear resection margin least 2 mm direction ; lobular histology DCIS histology resection margin must clear least 5 mm . For DCIS : lesion must classify low intermediate risk group ( Van Nuys Prognostic Index &lt; 8 ) . Unifocal unicentric DCIS breast cancer . Age &gt; = 40 year . Time interval final definitive breast surgical procedure start external beam therapy brachytherapy le 12 week ( 84 day ) . If patient receive chemotherapy radiotherapy start systemic treatment ( within 12 week ) . The radiation therapy also give interval chemotherapy course . It also possible start radiation therapy chemotherapy complete accord local protocol soon possible within 4 week chemotherapy . Signed studyspecific consent form prior randomization . Stage III IV breast cancer . Surgical margin microscopically assess . Extensive intraductal component ( EIC ) . Paget 's disease pathological skin involvement . Synchronous previous breast cancer . Prior malignancy ( &lt; 5 year prior enrollment study ) except nonmelanoma skin cancer cervical carcinoma FIGO 0 I patient continuously diseasefree . Pregnant lactating woman . Collagen vascular disease . The presence congenital disease increase radiation sensitivity , example Ataxia telangiectatica similar . Psychiatric disorder . Patient breast deem technically unsatisfactory brachytherapy .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>accelerate partial breast irradiation</keyword>
	<keyword>multicatheter brachytherapy</keyword>
	<keyword>high dose rate brachytherapy</keyword>
	<keyword>pulse dose rate brachytherapy</keyword>
</DOC>